Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.720
-0.010 (-0.58%)
Sep 25, 2026, 11:11 AM EDT - Market open
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of $200.65 million as of September 25, 2026. Its market cap has increased by 120.37% in one year.
Market Cap
200.65M
Enterprise Value
182.29M
1-Year Change
120.37%
Ranking
Category
Stock Price
$1.72
ChartMarket Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from $69.77M to $200.65M, an increase of 187.60%. That is a compound annual growth rate of 14.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 200.65M | 111.04% |
| Dec 31, 2025 | 95.08M | -9.38% |
| Dec 31, 2024 | 104.92M | 93.06% |
| Dec 29, 2023 | 54.35M | 67.34% |
| Dec 30, 2022 | 32.48M | -71.06% |
| Dec 31, 2021 | 112.23M | 56.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioAge Labs | 388.29M |
| Emergent BioSolutions | 346.61M |
| Anika Therapeutics | 279.57M |
| Akebia Therapeutics | 271.56M |
| Aurora Cannabis | 260.90M |
| SIGA Technologies | 234.23M |
| Journey Medical | 204.63M |
| Organogenesis Holdings | 190.44M |